Verfahren zur Hochpräzisen Krebszellenunterscheidung und Systeme dafür
Anmelder: Becton Dickinson and Company 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP4782813
- Anmeldetag
- 19. Januar 2026
- Veröffentlichung
- 29. Juli 2026
- Rechtsraum
- EP
Abstract
Aspects of the present disclosure include systems for detecting and classifying a cancerous cell in a whole blood sample in a flow stream. Systems according to certain embodiments include a light source configured to irradiate cells of a whole blood sample in a flow stream, a light detection system comprising a photodetector capturing an image of light emitted from the irradiated cells and a processor having memory operably coupled to the processor where the memory includes instructions stored thereon, which when executed by the processor, cause the processor to apply a neural network to the captured image to detect a presence of a cancerous cell in the whole blood sample having a minimum concentration of the cancerous cell and determine a classification of the cancerous cell of a plurality of classifications. In some instances, the neural network is trained using images of a sample tagged with a fluorophore ground truth marker. Methods for using the subject systems to detect and classify cancerous cells in a whole blood sample are also described. Non-transitory computer readable storage media are also provided.
Anmelder
- Firma
- Becton Dickinson and Company
- Land
- 🇺🇸 USA
US-amerikanisches Medizintechnikunternehmen mit Sitz in Franklin Lakes, New Jersey. Entwickelt medizinische Geräte, Diagnostiksysteme, Injektions- und Infusionstechnik sowie Laborausrüstung für Kliniken und Forschung.
3.997 Patente in unserer Datenbank
Vertreten von
-
Arnold & Siedsma
Arnold & Siedsma · Den Haag